This afternoon we watched GE HealthCare Technologies drop -2.9% to a price of $80.97 per share. The Large-Cap Medical Electronics company is now trading -13.59% below its average target price of $93.71. Analysts have set target prices ranging from $86.0 to $105.0 per share for GE HealthCare Technologies, and have given the stock an average rating of buy.
The stock has an average amount of shares sold short at 3.2%, and a short ratio of 3.91. The company's insiders own 6.93% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 73.3% of GE HealthCare Technologies's shares being owned by this investor type.
Institutions Invested in GE HealthCare Technologies
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-12-31 | General Electric Company | 13% | 61,581,302 | $4,986,545,835 |
| 2023-12-31 | Capital Research Global Investors | 11% | 51,344,719 | $4,157,638,542 |
| 2024-03-31 | Vanguard Group Inc | 11% | 48,519,340 | $3,928,853,482 |
| 2024-03-31 | Blackrock Inc. | 7% | 31,045,833 | $2,513,936,279 |
| 2023-12-31 | State Street Corporation | 4% | 18,583,969 | $1,504,836,861 |
| 2023-12-31 | Dodge & Cox Inc | 4% | 16,979,428 | $1,374,909,156 |
| 2023-12-31 | Price (T.Rowe) Associates Inc | 3% | 12,093,907 | $979,304,100 |
| 2023-12-31 | Geode Capital Management, LLC | 2% | 7,733,367 | $626,209,381 |
| 2023-12-31 | T. Rowe Price Investment Management, Inc. | 2% | 7,258,859 | $587,786,096 |
| 2023-12-31 | Hotchkis & Wiley Capital Management, LLC | 1% | 5,511,973 | $446,332,005 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on GE HealthCare Technologies.
